ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development

Prostate Cancer and Prostatic Diseases, Published online: 10 February 2021; doi:10.1038/s41391-021-00322-7ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development

Source: Prostate Cancer and Prostatic Diseases - February 10, 2021 Category: Urology & Nephrology Authors: Haiqing He Jun Hao Xin Dong Yu Wang Hui Xue Sifeng Qu Stephen Yiu Chuen Choi Xinpei Ci Yong Wang Rebecca Wu Mingchen Shi Xiaokun Zhao Colin Collins Dong Lin Yuzhuo Wang Source Type: research